arqule

All moves recorded at 10:20 a.m. EST Gainers PRC Therapeutics (NASDAQ: PTCT) - 50 percent Prosensa Holding N.V. (NASDAQ: RNA) - 27 percent Tuniu (NASDAQ: TOUR) - 19 percent Sportman's Warehouse (NASDAQ: SPWH) - 12 percent ZIOPHARM Oncology (NASDAQ: ZIOP) - 10 percent Wave...

Global Hunter is out with its report today on ArQule (NASDAQ: ARQL), initiating ARQL at Accumulate. In a note to clients, Global Hunter writes, "We are initiating coverage of ARQL with an Accumulate rating and $11 price target. ARQL is focused on the development of small molecule drugs for cancer...

BMO Capital Markets has initiated coverage for Arqule (NASDAQ: ARQL) with an Outperform rating.